The Insider Report: Prepare for the Next Dip Buying Opportunity

Benzinga_recent_news

11/16

Stocks finished mixed last week, with only the tech-heavy Nasdaq finishing lower by 0.45%. The S&P 500 and Dow Jones Industrial Average squeezed out gains, finishing up 0.08% and 0.34%, respectively. ...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2583266260"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2583266260\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2583266260?lang=zh_CN&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/16/investor-charts-ai4.png?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-11-16 21:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583266260","market":"us","top_or_hot":-1,"title":"The Insider Report: Prepare for the Next Dip Buying Opportunity","media":"Benzinga_recent_news","content":"<div>\n<p>Stocks finished mixed last week, with only the tech-heavy Nasdaq finishing lower by 0.45%. The S&P 500 and Dow Jones Industrial Average squeezed out gains, finishing up 0.08% and 0.34%, respectively. ...</p>\n\n<a href=\"https://www.benzinga.com/Opinion/25/11/48888849/the-insider-report-prepare-for-the-next-dip-buying-opportunity\">网页链接</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Insider Report: Prepare for the Next Dip Buying Opportunity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Insider Report: Prepare for the Next Dip Buying Opportunity\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-16 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/Opinion/25/11/48888849/the-insider-report-prepare-for-the-next-dip-buying-opportunity><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks finished mixed last week, with only the tech-heavy Nasdaq finishing lower by 0.45%. The S&P 500 and Dow Jones Industrial Average squeezed out gains, finishing up 0.08% and 0.34%, respectively. ...</p>\n\n<a href=\"https://www.benzinga.com/Opinion/25/11/48888849/the-insider-report-prepare-for-the-next-dip-buying-opportunity\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LQD","symbol_name":"债券指数ETF-iShares iBoxx投资级公司债","start_time":0,"source_url":"https://www.benzinga.com/Opinion/25/11/48888849/the-insider-report-prepare-for-the-next-dip-buying-opportunity","article_id":"2583266260","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/16/investor-charts-ai4.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/Opinion/25/11/48888849/the-insider-report-prepare-for-the-next-dip-buying-opportunity","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2583266260","pubTimestamp":1763299200,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Stocks finished mixed last week, with only the tech-heavy Nasdaq finishing lower by 0.45%. The S&P 500 and Dow Jones Industrial Average squeezed out gains, finishing up 0.08% and 0.34%, respectively. There's a defensive rotation taking place right now, and a lot of the high-flying momentum names have come down hard. Even so, there's a whole new batch of opportunities forming right now, mostly in healthcare and biotech.The reopening of the US government following the longest shutdown in history could give stocks the juice they need for a rally into year-end. Let's see if the anxieties over prolonged economic disruptions like delayed federal data releases and furloughed worker spending cuts have been fully priced in.Estimates suggests that the shut down shaved roughly 0.2 percentage points off GDP on a weekly basis. However, stocks have historically performed well coming out of government shutdowns – but the big question is – how much of this has already been priced in?This looks to be s","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LQD":"债券指数ETF-iShares iBoxx投资级公司债","OEF":"标普100指数ETF-iShares","BK4561":"索罗斯持仓","BK4581":"高盛持仓","XLV":"健康照护类股ETF-SPDR","SH":"标普500反向ETF","UPRO":"三倍做多标普500ETF","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","XLK":"高科技指数ETF-SPDR","XLY":"消费品指数ETF-SPDR可选消费品","LABU":"三倍做多标普生物-Direxion","OEX":"标普100","IBB":"生物科技指数ETF-iShares Nasdaq","XBI":"SPDR S&P Biotech ETF","XLP":"消费品指数ETF-SPDR主要消费品","SPXU":"三倍做空标普500ETF","IEI":"iShares Barclays 3-7 Year Trea","BK4504":"桥水持仓","BK4559":"巴菲特持仓","SSO":"两倍做多标普500ETF","BK4588":"碎股","SDS":"两倍做空标普500ETF","BK4550":"红杉资本持仓","IVV":"标普500指数ETF","DBC":"商品指数ETF-PowerShares DB","SPY":"标普500ETF"},"translate_title":"内幕报告：为下一次逢低买入机会做好准备","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLY":1,"XLV":1,"XLP":1,"XLK":1,"LQD":1,"IEI":1,"IBB":1,"SPY":1,"DBC":1,"IVV":0.6,"SPXU":0.6,"SSO":0.6,"UPRO":0.6,"SH":0.6,"SDS":0.6,"XBI":0.6,"OEX":0.6,"OEF":0.6,"LABU":0.6,"MESmain":0.6,"ESmain":0.6},"content_text":"Stocks finished mixed last week, with only the tech-heavy Nasdaq finishing lower by 0.45%. The S&P 500 and Dow Jones Industrial Average squeezed out gains, finishing up 0.08% and 0.34%, respectively. There's a defensive rotation taking place right now, and a lot of the high-flying momentum names have come down hard. Even so, there's a whole new batch of opportunities forming right now, mostly in healthcare and biotech.\nThe reopening of the US government following the longest shutdown in history could give stocks the juice they need for a rally into year-end. Let's see if the anxieties over prolonged economic disruptions like delayed federal data releases and furloughed worker spending cuts have been fully priced in.\nEstimates suggests that the shut down shaved roughly 0.2 percentage points off GDP on a weekly basis. However, stocks have historically performed well coming out of government shutdowns – but the big question is – how much of this has already been priced in?\nOne thing for sure is – there's a massive rotation taking place underneath the surface of the market. The leading themes from earlier this year are now starting to struggle, as setups in healthcare and financials start to blossom. The next stage of the market cycle appears to be taking hold.\nIt looks like another round of stimulus checks are coming for the economy. The timing is still up in the air, but most Americans will spend it away quickly. Others may opt to try their fortune in trading, which could add some more speculative flavor to the market.\nIn reality, the inflation story is at the mercy of commodity prices. Stimulus checks will get people spending again, and with that, the potential for money velocity (a key factor in inflation) could surge. Velocity is simply how fast money changes hands – the faster it does, the higher inflation gets.\nThe Fed wants to lower rates. I think they will again in December. Coupled with the end of quantitative tightening, the amount of liquidity about to be sent into the market will be astronomical. The inflation line the Fed is walking here is a very tight one – they need to tread carefully.\nThere's been some pretty remarkable developments over the past week here, as technology (XLK) is barely holding on to its position as the top-performing sector since the start of Q3. Now we have healthcare (XLV) vying for pole position.\nI'm okay with seeing healthcare's comeback – but let me be clear – this completely changes the dynamic of the market. The high-flying tech names are due for a rest here, and the more conservative names in healthcare have begun to rip.\nWe still see consumer staples (XLP) at the bottom of the pack – I'm glad to see this. But consumer discretionary (XLY) has slipped notably, which isn't a good sign near-term. It's pretty unstable across the board at the moment.\nEditor's Note: Healthcare's momentum is accelerating.\nThis looks to be shaping up us the strongest theme going into year-end and into the first quarter of 2026. In recent weeks, I've been highlighting the emerging strength of the healthcare sector, and how it's on the verge of taking some of the burden off the shoulders of tech.\nRemember, healthcare is the second-largest sector of the S&P 500 behind tech. It's not done much over the past year. The healthcare sector hasn't hit a new all-time high since September 2024.\nBut it's the biotech sector (IBB) that I'm watching most closely. It falls within the broader healthcare (XLV) umbrella, and the fact that we've already broken out from the rounding bottom pattern, and created higher-highs and higher-lows is sending a signal that a new uptrend is in effect here. Biotech is going to be a big story.\nThere's a battle going on when it comes to inflation right now. Crude oil prices aren't rising meaningfully, and it's creating tension for those looking for higher prices imminently. But I want to highlight the ratio between commodities (DBC) and the S&P 500 (SPY) to illustrate how to play rising prices.\nCommodities (DBC) will outperform when inflation pressures are accelerating. Stocks (SPY) will outperform when inflation pressures are present, but not increasingly on a regular basis. Hence why this ratio has been dropping for a few years now.\nIf inflation starts accelerating again, it'll be time to rotate back into commodities. But until then, it's better off to be overweight stocks. Keep an eye on energy prices, because if they start climbing again, I'd expect DBC to start outperform SPY by a notable margin.\nThe ratio I'm sharing here, between investment-grade corporate debt (LQD) and 3-7 Year Treasuries (IEI) is my favorite when it comes to measuring market liquidity. Remember, bond markets are way bigger than stock markets. Bonds lead, stocks follow.\nNow, this leadership doesn't have to be in any particular direction. Bonds can be bullish while stocks are bearish, and vice versa. In fact, they can even trend in the same direction. It just depends on the overall macro environment.\nWhen high-quality corporate debt outperforms Treasuries, which are considered to be the \"risk free\" asset, it's a good signal from the bond market. It means that investors have the confidence to take on an additional level of risk. When Treasuries outperform, it signals underlying issues are rising.\nI've been monitoring this rounding bottom pattern for a couple of years now, and a breakout from this pattern would signal that liquidity conditions are set to improve tremendously. In fact, it's probably sniffing out the further rate cuts from the Fed now.\nOnce inflation makes its dreaded return, I would look for this ratio to start dropping hard. It would also mean that the Fed would face pressure to start raising rates again. Although based on what I'm seeing now, it seems like they would try to fight that pressure as much as possible.\nThe tension in the crypto market could be cut with a knife right now. I want to focus on Bitcoin again this week because it is the tide that lifts the rest of the ships. Right now, it's desperately holding onto support in the 100,00-105,000 zone.\nIf this level were to break, a final washout as low as 93,000-94,000 could pan out. However, I'm not seeing the same level of vulnerability in Ethereum as I am in Bitcoin, which says a lot about the stage of this decline.\nTo regain its bullish momentum, Bitcoin needs to close back above 110,000-113,000. It needs to hold within the wedge formation. The leaves the door open for an upside acceleration in time. If it drops to 93,000-94,000, it may not last very long.\nLegal Disclosures:\nThis communication is provided for information purposes only. \nThis communication has been prepared based upon information, including market prices, data and other information, from sources believed to be reliable, but Benzinga does not warrant its completeness or accuracy except with respect to any disclosures relative to Benzinga and/or its affiliates and an analyst’s involvement with any company (or security, other financial product or other asset class) that may be the subject of this communication. Any opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. Past performance is not indicative of future results. This communication is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Benzinga does not provide individually tailored investment advice. Any opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients. You must make your own independent decisions regarding any securities, financial instruments or strategies mentioned or related to the information herein. Periodic updates may be provided on companies, issuers or industries based on specific developments or announcements, market conditions or any other publicly available information. However, Benzinga may be restricted from updating information contained in this communication for regulatory or other reasons. Clients should contact analysts and execute transactions through a Benzinga subsidiary or affiliate in their home jurisdiction unless governing law permits otherwise.\nThis communication may not be redistributed or retransmitted, in whole or in part, or in any form or manner, without the express written consent of Benzinga. Any unauthorized use or disclosure is prohibited. Receipt and review of this information constitutes your agreement not to redistribute or retransmit the contents and information contained in this communication without first obtaining express permission from an authorized officer of Benzinga. Copyright 2022 Benzinga. All rights reserved.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}